Form 10-Q · Quarterly report
Meta Platforms 10-Q, filed Jul 30, 2026
- Filed
- CIK
- 0001326801
- Accession no.
- 0001628280-26-050705
Summary
Meta Platforms reported second-quarter 2026 total revenue of $60.80 billion, up 28% year over year, while income from operations fell 8% to $18.78 billion and net income was $15.85 billion. It also disclosed a May 2026 headcount reduction affecting about 8,000 employees and said regulatory and platform changes continue to pressure its advertising business.
Key points
- Total revenue was $60.80 billion for Q2 2026, up 28% year over year; ad impressions rose 14% and average price per ad rose 12%.
- Income from operations was $18.78 billion, down 8% year over year; net income was $15.85 billion and diluted EPS was $6.18.
- Family daily active people averaged 3.60 billion in June 2026, up 3% year over year; headcount was 75,472 as of June 30, 2026, down 1% year over year, including about 8,000 employees impacted by the May 2026 headcount reduction.
- Capital expenditures including principal payments on finance leases were $31.08 billion; cash, cash equivalents, and marketable securities were $90.26 billion and long-term debt was $83.66 billion as of June 30, 2026.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2.Management's Discussion and Analysis of Financial Condition and Results of Operations You should read the following discussion of our financial condition and results of operations in conjunction with our condensed consolidated financial statements and the related notes included elsewhere in this Quarterly Report on Form 10-Q and with our audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the Securities and Exchange Commission. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.